Hygieia, Inc.
Hygieia is a digital health company dedicated to making insulin therapy easier and more effective for everyone involved. Founded in 2008 out of the University of Michigan, it develops innovative solutions such as the FDA-cleared d-Nav® Program, which uses AI-powered technology to support insulin management for people with diabetes. The company's mission is to improve clinical outcomes, reduce healthcare costs, and enhance the quality of life for patients with diabetes through advanced digital tools and clinical support.
Industries
Nr. of Employees
small (1-50)
Hygieia, Inc.
28803 8 Mile Rd, Suite 101, Livonia, Michigan 48152
Patents
Apparatus and method for taking blood glucose measurements and recommending insulin doses
US-11826142-B2
View DetailsSystems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
US-11723592-B2
View Details
Apparatus and method for taking blood glucose measurements and recommending insulin doses
US-11826142-B2
View DetailsSystems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
US-11723592-B2
View DetailsProducts
Mobile insulin-titration application
A mobile application that accepts glucose event data, applies insulin-titration algorithms, and provides individualized dose recommendations to patients; cleared by FDA for use as an aid in optimizing insulin management.
Handheld glucose monitor and supply provisioning
Provisioning of a handheld glucose monitor pre-loaded with the titration application, plus test strips and lancets, delivered to patient homes as part of the virtual service.
Mobile insulin-titration application
A mobile application that accepts glucose event data, applies insulin-titration algorithms, and provides individualized dose recommendations to patients; cleared by FDA for use as an aid in optimizing insulin management.
Handheld glucose monitor and supply provisioning
Provisioning of a handheld glucose monitor pre-loaded with the titration application, plus test strips and lancets, delivered to patient homes as part of the virtual service.
Services
A virtual clinical program that combines cloud-based insulin-titration algorithms with remote clinician teams to provide frequent individualized insulin dose recommendations, structured follow-up, and clinician reporting.
Secure clinician access to patient data, contact history, lab results, and device uploads to support oversight and triage of patients enrolled in the insulin guidance program.
A virtual clinical program that combines cloud-based insulin-titration algorithms with remote clinician teams to provide frequent individualized insulin dose recommendations, structured follow-up, and clinician reporting.
Secure clinician access to patient data, contact history, lab results, and device uploads to support oversight and triage of patients enrolled in the insulin guidance program.
Expertise Areas
- Automated insulin titration
- Digital health / mobile health
- Remote patient monitoring and telehealth
- Clinical trial design and execution
Key Technologies
- AI-driven titration algorithms
- Cloud-based analytics and data storage
- Mobile health applications (iOS/Android)
- Interoperability with glucose meters
News & Updates
Hygieia announced that it received FDA clearance for a phone app that further enhances the d-Nav® Insulin Guidance Service. The app is the first to titrate all types of insulin regimens and connect to any glucose meter sharing data with the cloud, making insulin management more accessible and effective.
A health economic evaluation conducted with Blue Cross Blue Shield of Michigan showed that the d-Nav Service significantly improves insulin use and glycemic control, leading to cost savings of nearly $62 million annually for a health plan with 10,000 patients in the target group.
A six-month, multi-site, randomized controlled clinical study evaluated the impact of the d-Nav system among insulin users with Type 2 diabetes, showing superior glycemic control compared to support alone.
Hygieia announced that it received FDA clearance for a phone app that further enhances the d-Nav® Insulin Guidance Service. The app is the first to titrate all types of insulin regimens and connect to any glucose meter sharing data with the cloud, making insulin management more accessible and effective.
A health economic evaluation conducted with Blue Cross Blue Shield of Michigan showed that the d-Nav Service significantly improves insulin use and glycemic control, leading to cost savings of nearly $62 million annually for a health plan with 10,000 patients in the target group.
A six-month, multi-site, randomized controlled clinical study evaluated the impact of the d-Nav system among insulin users with Type 2 diabetes, showing superior glycemic control compared to support alone.